A life-saving partnership with Toyota Material Handling
Read more about the partnership, which includes vital financial support for MIA research, and also awareness initiatives for the logistics sector.
Read more about the partnership, which includes vital financial support for MIA research, and also awareness initiatives for the logistics sector.
A contemporary overview of Cutaneous melanoma, co-authored by MIA, has been published in The Lancet, one of the world's leading medical journals.
This prestigious award from the 'Society for Melanoma Research' recognises the contribution Richard has made to global melanoma research over the course of his career.
Gina Savage was a bright light to all who knew and loved her. We have created this tribute page so everyone can share their messages and memories.
The PBAC recommends expanding current PBS listing for pembrolizumab immunotherapy to allow neoadjuvant (before surgery) treatment of resected stage IIIB-D melanoma.
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
Read more about how the MIA team continues to play a leading role in pushing melanoma research boundaries at ASCO23, the world's leading clinical oncology conference.
Read more about why Prof Richard Scolyer AO received the IAP Distinguished Pathologist Medal and watch his inspiring acceptance speech.
This is the highest award from the American Society of Dermatopathology, and recognises Prof Scolyer's significant contribution to the field of #dermatopathology.
Reflect on a wonderful Melanoma March 2023 - and view our photo albums from each event.